mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
BRD-K03536150 |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.1 |
mRNA |
fingolimod |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
BRD-M00053801 |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.1 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.1 |
mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.1 |
mRNA |
BIBR-1532 |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |